G. Yi

Safety and Stability of Antibody-Dye Conjugate in Optical Molecular Imaging

N. S. van den Berg, E. Rosenthal, G. Lu, 2020, Molecular Imaging and Biology.

EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial

N. S. van den Berg, Chirag B. Patel, E. Rosenthal, 2021, Theranostics.

Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study.

N. S. van den Berg, B. Martin, E. Rosenthal, 2020, The lancet. Gastroenterology & hepatology.

Tumor-Specific Fluorescence-Guided Surgery for Pancreatic Cancer Using Panitumumab-IRDye800CW: A Phase I Dose-Escalation study

B. Martin, E. Rosenthal, G. Lu, 2020 .

Factors for Differential Outcome Across Cancers in Clinical Molecule-Targeted Fluorescence Imaging

N. S. van den Berg, B. Martin, E. Rosenthal, 2022, The Journal of Nuclear Medicine.

Applications of fluorescence-guided surgery across multiple tumor types using a near-infrared labeled EGFR antibody

N. S. van den Berg, B. Martin, E. Rosenthal, 2021, medRxiv.

CTNI-42. FIRST-IN-HUMAN FLUORESCENCE GUIDED SURGERY OF HIGH-GRADE GLIOMAS USING PANITUMUMAB-IRDYE800

E. Rosenthal, H. Vogel, G. Lu, 2020, Neuro-Oncology.